Remove tag european
article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified.

article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

Tag Copenhagen A/S (Denmark). billion by 2027 appeared first on European Pharmaceutical Review. Kaneka Corporation (Japan). Thermo Fisher Scientific, Inc. (US). Twist Bioscience Corporation (US). Maravai Life Sciences (US). Merck KGaA (Germany). Microsynth AG (Switzerland). Sarepta Therapeutics, Inc. (US).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Smart contracts, which are essential for easing international trade and logistics operations, can enable the user to track fake returns to the producer and supplier using RFID tags. The post Benefits of blockchain in limiting counterfeit drug distribution appeared first on European Pharmaceutical Review.

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

In the EU however, two years later, the European Commission awarded a conditional marketing authorisation for Roctavian. BioMarin previously said that the treatment’s European price would likely be around EUR1.5 The European Commission withdrew the marketing authorisation of Zynteglo, at the request of bluebird bio, in March 2022.

Safety 111
article thumbnail

J&J gets first approval for multiple myeloma bispecific Tecvayli

pharmaphorum

Tecvayli (teclistamab) has been approved by the European Commission for adults with the blood cancer whose disease has progressed have after at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 antibody, said J&J.

FDA 95
article thumbnail

Novel nanofiltration method for microbial biosurfactant downstream processing

European Pharmaceutical Review

Methods of the microbial biosurfactant study The first stage of the downstream method combined TAG selective removal from glycolipids. The post Novel nanofiltration method for microbial biosurfactant downstream processing appeared first on European Pharmaceutical Review. Overall, Nascimento et al. The paper was published in Membranes.

article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The